Hls Therapeutics Inc (HLS.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2019 | 06-2019 | 03-2019 | 12-2018 | 09-2018 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 51,343 | 52,308 | 12,812 | 10,930 | 9,907 |
| Receivables | 9,618 | 11,075 | 13,344 | 17,509 | 19,012 |
| Inventories | 1,835 | 1,831 | 1,560 | 1,505 | 1,992 |
| Other current assets | 76 | 116 | 401 | 755 | 269 |
| TOTAL | $64,649 | $66,859 | $28,973 | $31,618 | $32,395 |
| Non-Current Assets | |||||
| PPE Net | 1,307 | 1,210 | 1,288 | 363 | 391 |
| Intangibles | 254,189 | 263,378 | 266,343 | 271,153 | 286,729 |
| Other Non-Current Assets | 3,213 | 3,271 | 3,216 | 3,291 | 3,284 |
| TOTAL | $258,709 | $267,859 | $270,847 | $274,807 | $290,404 |
| Total Assets | $323,358 | $334,718 | $299,820 | $306,425 | $322,799 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 5,000 | 5,000 | 5,000 | 5,000 | N/A |
| Accounts payable and accrued liabilities | 11,907 | 13,393 | 10,591 | 12,405 | 12,861 |
| Other current liabilities | 12,848 | 13,724 | 13,792 | 13,920 | 19,303 |
| TOTAL | $36,301 | $39,266 | $36,771 | $38,268 | $38,528 |
| Non-Current Liabilities | |||||
| Long Term Debt | 88,334 | 89,460 | 90,584 | 91,707 | 97,819 |
| Other Non-Current Liabilities | 6,340 | 8,865 | 10,359 | 12,752 | 14,569 |
| TOTAL | $98,514 | $102,382 | $106,093 | $109,668 | $117,405 |
| Total Liabilities | $134,815 | $141,648 | $142,864 | $147,936 | $155,933 |
| Shareholders' Equity | |||||
| Common Shares | 245,314 | 245,313 | 210,360 | 210,360 | 210,360 |
| Retained earnings | -68,070 | -64,912 | -62,114 | -57,389 | -56,742 |
| Other shareholders' equity | -3,135 | -1,287 | -4,497 | -7,455 | 523 |
| TOTAL | $188,543 | $193,070 | $156,956 | $158,489 | $166,866 |
| Total Liabilities And Equity | $323,358 | $334,718 | $299,820 | $306,425 | $322,799 |